NYU – Eli Lilly Drug Trial: Onward!

Alright, so tomorrow I leave for NYC again – one last round of trial meds to go! I’m excited to try it, and I’m excited to be done with it for awhile, because once I get back I can once again focus on my health.

For the past six weeks I haven’t been able to take any medications or supplements (such as Melatonin) that might alter the brain scans, and have been under certain nutritional restrictions as well; for example, no caffeine or grapefruit. It feels like things have been on hold, and I’m ready go push forward.

One week from today I’ll be DONE! WOOOHOOO!

Here’s some info on the next study:
On ClinicalTrials.gov: https://clinicaltrials.gov/ct2/show/NCT02234687

To evaluate the effect of 160mg and 40mg challenge of the mGlu2/3 receptor agonist pomaglumetad methionil relative to placebo in mitigating fear-potentiated startle using the neutral-predictable-unpredictable fear-potentiated startle paradigm in adults with post-traumatic stress disorder (PTSD). The primary index of unpredictable fear will be the difference score between startle magnitude in safe and unpredictable conditions in the absence of the cue.

Leave a Reply